Confirmed speakers and provisional titles:

Thursday, April 27, 2017

08:15-08:45 Continental Breakfast
08:45-09:00 Introduction - J. Woodgett/D. Drucker
09:00-09:25 Domenico Accili, Columbia University
When beta cells fail: lessons from dedifferentiation
09:25-09:40 Q&A
09:40-10:05 Patricia Brubaker, University of Toronto
Enteroendocrine L cells and GLP-1 secretion
10:05-10:20 Q&A
10:20-10:45 Darleen Sandoval, University of Michigan
New metabolic mechanisms for GLP-1 action
10:45-11:00 Q&A
Trainee Presentations
11:00-11:15 Darline Garibay, Cornell University
Beta Cell GLP-1R is necessary for increases in intra-islet glucagon-like- peptide 1 after vertical sleeve gastrectomy in mice
11:15-11:30 Anna Lam, University of Alberta
Early islet engraftment measured by BETA-2 score predicts islet transplant outcomes
11:30-11:45 Erin Mulvihill, University of Toronto
Inhibition of endothelial cell dipeptidyl peptidase-4 reduces post-prandial triglyceride secretion
11:45-12:00 Sarah Wheeler, University of Toronto
The SNARE protein, syntaxin1a, plays an essential role in biphasic exocytosis of the incretin hormone, glucagon-like peptide-1
12:15-13:00 Lunch Break
13:00-13:25 Jens Holst, University of Copenhagen
GLP-1, obesity and bariatric surgery
13:25-13:40 Q&A
13:40-14:05 Daniel Drucker, LTRI, University of Toronto
Revisiting traditional concepts of incretin action
14:05-14:20 Q&A
14:20-14:45 Michael Nauck, Ruhr University Bochum
Clinical outcomes with incretin-based therapies
14:45-15:00 Q&A
15:00-15:25 Matthias Tschoep, Helmholtz Diabetes Center
GLP-1-Incretin therapies-the next generation
15:25-15:40 Q&A
15:40-15:45 Summary & Closing – Daniel Drucker